课题基金 / 基金详情

CLINICAL TRIAL: PK STUDY OF INTRANODAL INJECTION OF ADENOVIRUS-CD154 IN PATIENTS

CLINICAL TRIAL: PK STUDY OF INTRANODAL INJECTION OF ADENOVIRUS-CD154 IN PATIENTS
临床试验：腺病毒-CD154节内注射患者体内的药代动力学研究
批准号：
7950956
负责人：
JANUARIO E CASTRO
金额：
$2.04万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
项目状态：
已结题
起止时间：
2008-12-01 至 2009-11-30
来源：
https://reporter.nih.gov/project-details/7950956
关键词：
AdenovirusesClinical ResearchClinical TrialsComputer Retrieval of Information on Scientific Projects DatabaseDoseFundingGrantInjection of therapeutic agentInstitutionPatientsResearchResearch PersonnelResourcesSafetySourceUnited States National Institutes of Healthlymph nodes

项目摘要

项目成果

JANUARIO E CASTRO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Determine the safety and maximun tolerated dose of Adenovirus-CD154 (AD-ISF35) when injected directly into the lymph nodes of patients with CLL/SLL.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: ADENOVIRUS CD-154 IN SUBJECTS WITH CLL
CLINICAL TRIAL: A PHASE II STUDY OF REPEAT INTRANODAL INJECTIONS OF ADENOVIRUS-C
Phase I, Open-Label Dose-Escalation
Phase I, Open-Label Dose-Escalation
海外基金